MKS (NASDAQ:MKSI) Price Target Raised to $215.00 at Bank of America

MKS (NASDAQ:MKSI) had its target price lifted by analysts at Bank of America from $200.00 to $215.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the scientific and technical instruments company’s stock. Bank of America‘s price objective indicates a potential upside of 15.64% from the company’s current price.

Several other research firms have also recently issued reports on MKSI. Wall Street Zen cut shares of MKS from a “strong-buy” rating to a “buy” rating in a research report on Saturday, January 3rd. Citigroup boosted their price objective on shares of MKS from $122.00 to $185.00 and gave the company a “buy” rating in a research note on Wednesday, November 12th. The Goldman Sachs Group upped their price objective on MKS from $92.00 to $125.00 and gave the stock a “sell” rating in a report on Thursday, October 9th. Weiss Ratings restated a “hold (c)” rating on shares of MKS in a research note on Wednesday, October 8th. Finally, Needham & Company LLC lifted their price objective on MKS from $136.00 to $170.00 and gave the company a “buy” rating in a research note on Thursday, November 6th. Nine analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, MKS currently has an average rating of “Moderate Buy” and an average price target of $176.91.

MKS Trading Down 0.1%

Shares of MKSI opened at $185.92 on Tuesday. MKS has a fifty-two week low of $54.84 and a fifty-two week high of $188.71. The company has a market capitalization of $12.49 billion, a PE ratio of 45.13, a price-to-earnings-growth ratio of 1.71 and a beta of 1.92. The stock has a fifty day moving average of $158.77 and a two-hundred day moving average of $130.02. The company has a debt-to-equity ratio of 1.64, a quick ratio of 1.81 and a current ratio of 2.86.

MKS (NASDAQ:MKSI) last posted its quarterly earnings data on Wednesday, November 5th. The scientific and technical instruments company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.80 by $0.13. The business had revenue of $988.00 million for the quarter, compared to analysts’ expectations of $963.87 million. MKS had a return on equity of 20.80% and a net margin of 7.25%.The business’s revenue was up 10.3% on a year-over-year basis. During the same quarter last year, the firm earned $1.72 earnings per share. MKS has set its Q4 2025 guidance at 1.930-2.610 EPS. As a group, analysts forecast that MKS will post 6.94 EPS for the current year.

Insider Transactions at MKS

In other MKS news, Director Elizabeth Mora sold 300 shares of the stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $158.81, for a total transaction of $47,643.00. Following the transaction, the director owned 18,963 shares of the company’s stock, valued at $3,011,514.03. This trade represents a 1.56% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 0.51% of the stock is owned by insiders.

Institutional Investors Weigh In On MKS

A number of institutional investors have recently made changes to their positions in MKSI. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in MKS by 3.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 267,421 shares of the scientific and technical instruments company’s stock worth $21,434,000 after purchasing an additional 9,170 shares during the last quarter. Parallel Advisors LLC increased its stake in MKS by 63.9% during the second quarter. Parallel Advisors LLC now owns 952 shares of the scientific and technical instruments company’s stock valued at $95,000 after purchasing an additional 371 shares during the last quarter. MassMutual Private Wealth & Trust FSB raised its holdings in shares of MKS by 265.5% during the second quarter. MassMutual Private Wealth & Trust FSB now owns 837 shares of the scientific and technical instruments company’s stock worth $83,000 after purchasing an additional 608 shares during the period. Wedmont Private Capital bought a new position in shares of MKS in the 2nd quarter worth about $280,000. Finally, Assenagon Asset Management S.A. bought a new position in shares of MKS in the 2nd quarter worth about $991,000. 99.79% of the stock is currently owned by institutional investors.

MKS Company Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.